Prognostic factors for survival in patients treated in phase I clinical trials
- 1 October 1994
- Vol. 74 (7) , 1965-1973
- https://doi.org/10.1002/1097-0142(19941001)74:7<1965::aid-cncr2820740723>3.0.co;2-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Statistical and Ethical Issues in the Design and Conduct of Phase I and II Clinical Trials of New Anticancer AgentsJNCI Journal of the National Cancer Institute, 1993
- Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinomaEuropean Journal Of Cancer, 1992
- Doxorubicin in advanced breast cancer: Influence of schedule on response, survival and quality of lifeEuropean Journal Of Cancer, 1992
- Predicting Life Span for Applicants toArchives of internal medicine (1960), 1988
- Inaccurate predictions of life expectancy. Dilemmas and opportunitiesArchives of internal medicine (1960), 1988
- A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1986
- PROGNOSTIC UNCERTAINTY IN TERMINAL CARE: CAN THE KARNOFSKY INDEX HELP?The Lancet, 1985
- Small cell lung cancer 1973–1983: Early progress and recent obstaclesInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Accuracy of Predictions of Survival in Later Stages of CancerBMJ, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958